These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

104 related items for PubMed ID: 6154464

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Tallysomycin, a new antitumor antibiotic complex related to bleomycin. II. Structure determination of tallysomycins A and B.
    Konishi M, Saito K, Numata K, Tsuno T, Asama K.
    J Antibiot (Tokyo); 1977 Oct; 30(10):789-805. PubMed ID: 591444
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Bifunctional intercalation of antitumor antibiotics BBM-928A and echinomycin with deoxyribonucleic acid. Effects of intercalation on deoxyribonucleic acid degradative activity of bleomycin and phleomycin.
    Huang CH, Prestayko AW, Crooke ST.
    Biochemistry; 1982 Jul 20; 21(15):3704-10. PubMed ID: 6180762
    [Abstract] [Full Text] [Related]

  • 8. The transition metal binding properties of a 3rd generation bleomycin analogue, tallysomycin.
    Greenaway FT, Dabrowiak JC, Van Husen M, Grulich R, Crooke ST.
    Biochem Biophys Res Commun; 1978 Dec 29; 85(4):1407-14. PubMed ID: 84672
    [No Abstract] [Full Text] [Related]

  • 9. A radioimmunoassay for tallysomycin.
    Broughton A, Strong JE, Crooke ST, Prestayko AW, Knight J.
    Cancer Treat Rep; 1979 Dec 29; 63(11-12):1829-32. PubMed ID: 93510
    [Abstract] [Full Text] [Related]

  • 10. Tallysomycin, a new antitumor antibiotic complex related to bleomycin. IV. New biosynthetic derivatives of tallysomycin.
    Miyaki T, Tenmyo O, Numata K, Matsumoto K, Yamamoto H, Nishiyama Y, Ohbayashi M, Imanishi H, Konishi M, Kawaguchi H.
    J Antibiot (Tokyo); 1981 Jun 29; 34(6):658-64. PubMed ID: 6168630
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Iron--dioxygen-dependent changes to the biological activities of bleomycin.
    Gutteridge JM, Shute DJ.
    J Inorg Biochem; 1981 Dec 29; 15(4):349-57. PubMed ID: 6172560
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Use of covalently closed circular deoxyribonucleic acid for prescreening for antitumor compounds.
    Mong S, Strong JE, Bush JA, Crooke ST.
    Antimicrob Agents Chemother; 1979 Sep 29; 16(3):398-405. PubMed ID: 507796
    [Abstract] [Full Text] [Related]

  • 17. Comparative analysis of the biosynthetic gene clusters and pathways for three structurally related antitumor antibiotics: bleomycin, tallysomycin, and zorbamycin.
    Galm U, Wendt-Pienkowski E, Wang L, Huang SX, Unsin C, Tao M, Coughlin JM, Shen B.
    J Nat Prod; 2011 Mar 25; 74(3):526-36. PubMed ID: 21210656
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Studies on the effects of the antitumor agent camptothecin and derivatives on DNA. Camptothecin potentiated cleavage of DNA by bleomycin in vitro.
    Lown JW, Chen HH, Plambeck JA.
    Chem Biol Interact; 1981 Apr 25; 35(1):55-70. PubMed ID: 6162579
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.